anmelden
NYSE International 100
11.010,16
PKT
-22,06
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.03.22 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.22 | BBVA Outperform | RBC Capital Markets | |
| 08.03.22 | Deutsche Bank Sector Perform | RBC Capital Markets | |
| 08.03.22 | Barclays Outperform | Credit Suisse Group | |
| 08.03.22 | UBS Outperform | Credit Suisse Group | |
| 08.03.22 | ING Group Outperform | Credit Suisse Group | |
| 08.03.22 | Deutsche Bank Underperform | Credit Suisse Group | |
| 08.03.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 08.03.22 | Siemens Underperform | Bernstein Research | |
| 08.03.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 08.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 08.03.22 | Lloyds Banking Group Overweight | Barclays Capital | |
| 08.03.22 | ING Group Underweight | Barclays Capital | |
| 08.03.22 | Imperial Brands Overweight | Barclays Capital | |
| 07.03.22 | Mercedes-Benz Group (ex Daimler) Outperform | RBC Capital Markets | |
| 07.03.22 | Santander Buy | UBS AG | |
| 07.03.22 | BBVA Neutral | UBS AG | |
| 07.03.22 | Sanofi Buy | UBS AG | |
| 07.03.22 | AstraZeneca Buy | UBS AG | |
| 07.03.22 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 07.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.03.22 | Nutrien (Ex Potash Agrium) Outperform | RBC Capital Markets | |
| 04.03.22 | Nutrien (Ex Potash Agrium) Neutral | JP Morgan Chase & Co. | |
| 04.03.22 | Unilever Sell | UBS AG | |
| 04.03.22 | Mercedes-Benz Group (ex Daimler) Buy | Deutsche Bank AG | |
| 03.03.22 | HSBC Outperform | RBC Capital Markets | |
| 03.03.22 | HSBC Neutral | Credit Suisse Group | |
| 03.03.22 | Prudential Overweight | JP Morgan Chase & Co. | |
| 03.03.22 | Philips Neutral | JP Morgan Chase & Co. | |
| 03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.03.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 02.03.22 | Mercedes-Benz Group (ex Daimler) Outperform | RBC Capital Markets | |
| 02.03.22 | Diageo Neutral | JP Morgan Chase & Co. | |
| 01.03.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.03.22 | GSK Neutral | UBS AG | |
| 01.03.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 01.03.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.02.22 | Nutrien (Ex Potash Agrium) Buy | UBS AG | |
| 28.02.22 | BP Hold | Jefferies & Company Inc. |
